COSCIENS Biopharma Inc. (CSCI)
NASDAQ: CSCI · Real-Time Price · USD
2.981
-0.019 (-0.64%)
Nov 20, 2024, 4:00 PM EST - Market closed
COSCIENS Biopharma Employees
COSCIENS Biopharma had 12 employees as of December 31, 2020. The number of employees decreased by 44 or -78.57% compared to the previous year.
Employees
12
Change
-44
Growth
-78.57%
Revenue / Employee
$402,833
Profits / Employee
-$1,934,083
Market Cap
9.34M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2020 | 12 | -44 | -78.57% |
| Dec 31, 2014 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ImmunoPrecise Antibodies | 101 |
| MSP Recovery | 88 |
| Turnstone Biologics | 80 |
| Aspira Women's Health | 64 |
| AIM ImmunoTech | 28 |
| Talphera | 15 |
| QT Imaging Holdings | 14 |
| Immuron | 7 |
CSCI News
- 8 days ago - COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs - GlobeNewsWire
- 6 weeks ago - COSCIENS Biopharma Announces Change to Board of Directors - GlobeNewsWire
- 7 weeks ago - COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director - GlobeNewsWire
- 2 months ago - COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs - GlobeNewsWire
- 3 months ago - COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency - GlobeNewsWire
- 3 months ago - COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results - GlobeNewsWire